1. Home
  2. NVTS vs EVO Comparison

NVTS vs EVO Comparison

Compare NVTS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVTS
  • EVO
  • Stock Information
  • Founded
  • NVTS 2014
  • EVO 1993
  • Country
  • NVTS United States
  • EVO Germany
  • Employees
  • NVTS N/A
  • EVO N/A
  • Industry
  • NVTS Semiconductors
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVTS Technology
  • EVO Health Care
  • Exchange
  • NVTS Nasdaq
  • EVO Nasdaq
  • Market Cap
  • NVTS 1.3B
  • EVO 1.2B
  • IPO Year
  • NVTS N/A
  • EVO 2021
  • Fundamental
  • Price
  • NVTS $7.85
  • EVO $3.94
  • Analyst Decision
  • NVTS Buy
  • EVO Strong Buy
  • Analyst Count
  • NVTS 7
  • EVO 1
  • Target Price
  • NVTS $4.93
  • EVO $7.00
  • AVG Volume (30 Days)
  • NVTS 27.9M
  • EVO 45.6K
  • Earning Date
  • NVTS 11-03-2025
  • EVO 11-05-2025
  • Dividend Yield
  • NVTS N/A
  • EVO N/A
  • EPS Growth
  • NVTS N/A
  • EVO N/A
  • EPS
  • NVTS N/A
  • EVO N/A
  • Revenue
  • NVTS $68,167,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • NVTS N/A
  • EVO N/A
  • Revenue Next Year
  • NVTS $8.28
  • EVO $10.78
  • P/E Ratio
  • NVTS N/A
  • EVO N/A
  • Revenue Growth
  • NVTS N/A
  • EVO N/A
  • 52 Week Low
  • NVTS $1.52
  • EVO $2.84
  • 52 Week High
  • NVTS $9.48
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • NVTS 61.60
  • EVO 62.09
  • Support Level
  • NVTS $7.50
  • EVO $3.47
  • Resistance Level
  • NVTS $8.49
  • EVO $4.06
  • Average True Range (ATR)
  • NVTS 0.60
  • EVO 0.09
  • MACD
  • NVTS 0.17
  • EVO 0.05
  • Stochastic Oscillator
  • NVTS 66.47
  • EVO 79.10

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: